Global Nebulizer Market By Devices (Pneumatic Nebulizer, Ultrasonic Nebulizer, Mesh Nebulizers), By End-User (Home, Hospital, Physician/Clinic) - Growth, Share, Opportunities & Competitive Analysis, 2016 - 2022

A nebulizer is a medication device that converts liquid into fine mist under a pressurized air pump. It uses oxygen, compressed air, or ultrasonic power to break medication solutions and deliver a therapeutic dose of aerosol particles directly to the lungs.

The report titled “Global Nebulizer Market - Growth, Share, Opportunities and Competitive Analysis, 2016–2022” offers strategic insights into the overall Nebulizer market along with the market size and estimates for the duration of 2016 to 2022. The said research study covers an in-depth analysis of multiple market segments based on the type of device, type of end users, and different geographical regions. The device type segment studied for analyzing the overall Nebulizer market is majorly segmented into Pneumatic nebulizer, Ultrasonic nebulizer, and Mesh nebulizer. Furthermore, on the type of End User, the Nebulizer market is segmented into Home, Hospital, and Physician/ Clinic.

In order to help strategic decision makers, the report also includes competitive profiling of the leading players in the Nebulizer market and attractive investment proposition market positioning of key manufacturers sections. Other in-depth analysis provided in the report includes:

Geographically, the global Nebulizer market is studied for the following regional markets:

  • North America
  • U.S.
  • Canada
  • Europe
  • U.K.
  • Germany
  • Rest of Europe
  • Asia-Pacific
  • China
  • Japan
  • Rest of Asia Pacific
  • Latin America
  • Middle East and Africa

Market size and forecast for these regional and country-level markets are presented in this study for the period 2013-2022. In addition, market growth rates for the forecast period 2016-2022 are also included in this report, considering 2015 as the base year.

Along with quantitative information, qualitative information sets and assessment tools are provided in this study for better analysis of the overall market scenario and prospects. Information such as market inclination insights and drivers, challenges, and opportunities assists the readers in understanding the ongoing trends in the global Nebulizer market. In addition, tools such as market positioning of key players and attractive investment propositions provide the readers with insights into the competitive scenario of the global Nebulizer market. This report concludes with a company profiles section highlighting major information about the key players engaged in the global Nebulizer market. In-depth competitive environment analysis and historical years (2013 & 2014) market size data are also provided in the report.

Thus, the research study provides the following:

  • A holistic view of the global Nebulizer market.
  • Offering market size and estimates for the period from 2016 to 2022.
  • Keeping in mind the above-mentioned factors.

Based on the type of device, the Global Nebulizer Market is segmented as follows:

  • Pneumatic Nebulizer
  • Breathe-Actuated Pneumatic Nebulizer
  • Vented Actuated Pneumatic Nebulizer
  • Ultrasonic Nebulizer
  • Mesh Nebulizer
  • Static Mesh Nebulizer
  • Vibrating Mesh Nebulizers

The nebulizer market is a medical device used for the treatment of respiratory diseases such as asthma, COPD, and cystic fibrosis. It converts the medical solution into an aerosol with different technology that can be easily inhaled into the lower respiratory tract. Technological advancement has segmented the nebulizer market into three types: Pneumatic, Ultrasonic, and Mesh. Amongst all, the Pneumatic nebulizer occupies the major share market, i.e., 63.83%, followed by the Mesh and Ultrasonic nebulizer. A pneumatic nebulizer is the most commonly used due to its easy usage, efficiency, and cost-benefit. It is further categorized into Breathe-Actuated Pneumatic Nebulizer and Vented Actuated Pneumatic Nebulizer. Breathe-Actuated Pneumatic Nebulizer generates and delivers according to the inspiratory manoeuvre of the patient, leading to economic usage of the drug. The Vented Actuated Pneumatic Nebulizer produces continuous during inspiratory and expiratory and breath holding acts. Ultrasonic nebulizers make use of piezoelectric crystal vibration of high frequencies (1-3 MHz) to generate aerosol. It is easy to use and efficient, and drug delivery is faster. The Vented Actuated Pneumatic Nebulizer occupies 60.2% market share of the Pneumatic Nebulizer market. With recent development, Mesh nebulizer has entered the market, which generates mist with the help of a micro pump. Mesh nebulizers use two different techniques to produce mist, therefore further segregated into Static and Vibrating Mesh Nebulizer. According to its name, the Static Mesh Nebulizer, with the aid of static sieving mesh through which the liquid medication is passed by pressure, produces the mist. A vibrating Mesh Nebulizer uses mesh deformation or vibration to pass the liquid medication through the mesh, which occupies a major share in mesh nebulizers. Mesh nebulizer is the fastest growing CAGR of 7.2% in 2013-2022 in the nebulizer market.

Based on the type of End User, the Global Nebulizer Market is segmented as follows:

  • Home
  • Hospital
  • Physician/Clinic

Global Nebulizer Market is segmented as mentioned above on the basis of the End user. Awareness of the treatment of respiratory diseases among patients and advancements in technology in the nebulizer market has caused a surge in-home care and self-medication among patient in North America, Europe, and developed nations of Asia-Pacific. The home care facility is preferred by the patient over the hospital and clinical care, especially for chronic and acute respiratory, due to the novel technology available in the market, which is user-friendly, portable, efficient, and affordable. Thus the home care segment occupies the major share in the end-user segment and is also the fastest-growing segment, followed by the physician. Another reason is the rising cost of hospitalization and the resultant high expenditure, which led to a rise in the home healthcare segment. The physician/clinic segment is anticipated to grow steadily during the forecast period due to the consumers' convenience, accessibility, and affordability. In underdeveloped and developing nations, people still opt for physicians and clinics for the treatment of various diseases, including respiratory conditions. The prime factor for this includes the low awareness about the disease, lesser knowledge about the first-line treatment, and negligible penetration of the nebulizer devices to the masses. Thus, the physician/clinic end-user segment is expected to grow at a steady rate during the forecast period.

For the purpose of this study, the Global Nebulizer Market is categorized into:

  • North America
  • Europe
  • Asia Pacific
  • Latin America (LATAM)
  • Middle East and Africa (MEA)

In the base year 2015, North America accounted for the largest share in 36%, in which the US occupies a major part, mainly due to key drivers such as a surge in diagnosis rates and availability of sophisticated healthcare infrastructure and reimbursement system. In addition, other factors, such as awareness among the patient population, high government funding, and extensive R&D investment in the respiratory device market, aim to innovate and rapidly commercialize novel therapeutic and disease management products. On the other hand, the Asia-Pacific CEA market is expected to grow at a CAGR of 8.3% throughout the forecast period from 2016 to 2023. The major factors assisting the exponential growth of this region are the increasing prevalence of asthma, COPD, and other chronic respiratory diseases, pollution, and lifestyle change. For example, according to WHO reports, the second most prominent cause of death in China is a respiratory disease, and in India, 12 million people are also affected by COPD. Thus, the Asia Pacific market includes rapid urbanization, changing lifestyles, increasing tobacco smokers, and growing healthcare expenditure.

Frequently asked questions :

The market for Nebulizer Market is expected to reach US$ XX Bn in 2022.

The Nebulizer Market market is expected to see significant CAGR growth over the coming years, at XX%.

The report is forecasted from 2016-2022.

The base year of this report is 2021.

Allied Healthcare Products, Inc., Becton Dickinson and Company (CareFusion), Medtronic PLC, DeVillbiss Healthcare LLC, Aerogen, PARI GmbH are some of the major players in the global market.

Choose License Type
Trusted By
Published Date:  Dec 2016
Category:  Medical Devices
Report ID:   57907
Report Format:   PDF
Pages:   120
Rating:    4.4 (55)
Delivery Time: 24 Hours to 48 Hours   
Connect With Us
24/7 Research Support